Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001011438-25-000384
Filing Date
2025-07-29
Accepted
2025-07-29 15:17:41
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 10909
2 exhibit_99-1.htm EX-99.1 32189
  Complete submission text file 0001011438-25-000384.txt   44819
Mailing Address 234 BATH ROAD SLOUGH, BERKSHIRE X0 SL1 4EE
Business Address 234 BATH ROAD SLOUGH, BERKSHIRE X0 SL1 4EE 804-379-1090
INDIVIOR PLC (Subject) CIK: 0001625297 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-94167 | Film No.: 251161013
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 32 ELM PLACE, 3RD FLOOR RYE NY 10580
Business Address 32 ELM PLACE, 3RD FLOOR RYE NY 10580 917.536.6028
Two Seas Capital LP (Filed by) CIK: 0001823138 (see all company filings)

EIN.: 843799363 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A